Expression patterns of USP22 and potential targets BMI-1, PTEN, p-AKT in non-small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Lung Cancer

• Publication date

  2012-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.lungcan.2012.05.112PMID 22717106
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated expression of USP22 in correlation with poor prognosis in patients with invasive breast cancer

  2011cited by this paper
• USP22 Acts as an Oncogene by the Activation of BMI-1-Mediated INK4a/ARF Pathway and Akt Pathway

  2011cited by this paper
• Aberrant expression of USP22 is associated with liver metastasis and poor prognosis of colorectal cancer

  2011cited by this paper
• The Co-expression of USP22 and BMI-1 May Promote Cancer Progression and Predict Therapy Failure in Gastric Carcinoma

  2011cited by this paper
• Lung cancer: New biological insights and recent therapeutic advances

  2011cited by this paper
• Combined modality therapy for stage III non-small-cell lung cancer.

  2010cited by this paper
• Concurrent chemoradiotherapy in non-small cell lung cancer.

  2010cited by this paper
• Stepwise progression of pulmonary adenocarcinoma—clinical and molecular implications

  2010cited by this paper
• Global Patterns of Cancer Incidence and Mortality Rates and Trends

  2010cited by this paper
• BMI1 and Mel-18 oppositely regulate carcinogenesis and progression of gastric cancer

  2010cited by this paper
• Increased expression of ubiquitin‐specific protease 22 can promote cancer progression and predict therapy failure in human colorectal cancer

  2010cited by this paper
• Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells

  2010cited by this paper
• The changing epidemiology of lung cancer.

  2009cited by this paper
• The putative cancer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression.

  2008cited by this paper
• Chemoradiation for unresectable stage III non-small cell lung cancer.

  2008cited by this paper
• "Stemness" genomics law governs clinical behavior of human cancer: implications for decision making in disease management.

  2008cited by this paper
• The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends

  2008cited by this paper
• Stem Cell Origin of Death-from-Cancer Phenotypes of Human Prostate and Breast Cancers

  2007cited by this paper
• Treatment of non-small cell lung cancer-stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).

  2007cited by this paper
• Constructing Molecular Classifiers for the Accurate Prognosis of Lung Adenocarcinoma

  2006cited by this paper
• Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts.

  2006cited by this paper
• Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells.

  2006cited by this paper
• Genomic Models of Metastatic Cancer: Functional Analysis of Death-from-Cancer Signature Genes Reveals Aneuploid, Anoikis-Resistant, Metastasis-Enabling Phenotype with Altered Cell Cycle Control and Activated PcG Protein Chromatin Silencing Pathway

  2006cited by this paper
• Stem cell-ness: a "magic marker" for cancer.

  2005cited by this paper
• Global Cancer Statistics, 2002

  2005cited by this paper
• Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer.

  2005cited by this paper
• American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003.

  2004cited by this paper
• Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation

  2003cited by this paper
• Lung cancer in Europe in 2000: epidemiology, prevention, and early detection.

  2003cited by this paper
• Bmi-1 is required for maintenance of adult self-renewing haematopoietic stem cells

  2003cited by this paper
• Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

  2003cited by this paper
• Molecular characteristics of non-small cell lung cancer

  2001cited by this paper

• LncRNA TAF1A-AS1 regulates the progression in hepatocellular carcinoma by targeting miR-664b-3p/USP22 axis

  2026cites this paper
• The structural, functional, and regulatory insight of de-ubiquitinating enzyme (USP22).

  2025cites this paper
• Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.

  2025cites this paper
• Non-small cell lung cancer map and analysis: exploring interconnected oncogenic signal integrators

  2025cites this paper
• Recent advances in the development of deubiquitinases inhibitors as antitumor agents.

  2024cites this paper
• Targeted therapy based on ubiquitin-specific proteases, signalling pathways and E3 ligases in non-small-cell lung cancer

  2023cites this paper
• Usp22 Deficiency Leads to Downregulation of PD-L1 and Pathological Activation of CD8+ T Cells and Causes Immunopathology in Response to Acute LCMV Infection

  2023cites this paper
• Renieramycin t derivative dh_22 induces apoptosis in lung cancer cells by downregulation of C-Myc protein

  2023cites this paper
• Immune Evasion and Drug Resistance Mediated by USP22 in Cancer: Novel Targets and Mechanisms

  2022cites this paper
• USP22 Contributes to Chemoresistance, Stemness, and EMT Phenotype of Triple-Negative Breast Cancer Cells by egulating the Warburg Effect via c-Myc Deubiquitination.

  2022cites this paper
• USP22 suppresses the NLRP3 inflammasome by degrading NLRP3 via ATG5-dependent autophagy

  2022cites this paper
• Ubiquitin-specific peptidase 22 in cancer.

  2021cites this paper
• Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis

  2020cites this paper
• RETRACTED ARTICLE: The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer

  2020cites this paper
• Deubiquitination in prostate cancer progression: role of USP22

  2020cites this paper
• USP22 promotes development of lung adenocarcinoma through ubiquitination and immunosuppression

  2020cites this paper
• Expression of PTEN and pAKT in Non-Small Cell Lung Cancer

  2019cites this paper
• Targeted eradication of gastric cancer stem cells by CD44 targeting USP22 small interfering RNA-loaded nanoliposomes.

  2019cites this paper
• Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling

  2019cites this paper
• Single-cell based elucidation of molecularly-distinct glioblastoma states and drug sensitivity

  2019cites this paper
• MicroRNA‐30e‐5p suppresses non‐small cell lung cancer tumorigenesis by regulating USP22‐mediated Sirt1/JAK/STAT3 signaling

  2018cites this paper
• Ubiquitin‐specific protease 22 acts as an oncoprotein to maintain glioma malignancy through deubiquitinating B cell‐specific Moloney murine leukemia virus integration site 1 for stabilization

  2018cites this paper
• USP22 promotes resistance to EGFR-TKIs by preventing ubiquitination-mediated EGFR degradation in EGFR-mutant lung adenocarcinoma.

  2018cites this paper
• Ubiquitin-specific protease 22 promotes the proliferation, migration and invasion of glioma cells

  2018influential citation
• MiR-30e-5p inhibits proliferation and metastasis of nasopharyngeal carcinoma cells by target-ing USP22.

  2018cites this paper
• Prognostic value of Bmi-1 oncoprotein expression in non-small cell lung cancer

  2018cites this paper
• Phosphatase and tensin homolog protein may be linked to lymph node metastasis and tumor node metastasis staging in nonsmall cell lung cancer

  2018cites this paper
• Clinicopathological significance of Bmi-1 overexpression in esophageal cancer: a meta-analysis.

  2018cites this paper
• Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis

  2017cites this paper
• Loss of phosphatase and tensin homolog expression correlates with clinicopathological features of non‐small cell lung cancer patients and its impact on survival: A systematic review and meta‐analysis

  2017cites this paper
• USP22 maintains gastric cancer stem cell stemness and promotes gastric cancer progression by stabilizing BMI1 protein

  2017cites this paper
• Bronchoalveolar Lavage: Quantitative Mass Spectrometry-Based Proteomics Analysis in Lung Diseases.

  2017cites this paper
• Deubiquitinating enzyme USP22 positively regulates c‐Myc stability and tumorigenic activity in mammalian and breast cancer cells

  2017influential citation
• Deubiquitylating enzymes and drug discovery: emerging opportunities

  2017cites this paper
• USP22 drives colorectal cancer invasion and metastasis via epithelial-mesenchymal transition by activating AP4

  2017cites this paper
• Downregulation of Ubiquitin-Specific Protease 22 Inhibits Proliferation, Invasion, and Epithelial–Mesenchymal Transition in Osteosarcoma Cells

  2017cites this paper
• Bmi-1 overexpression as an efficient prognostic marker in patients with nonsmall cell lung cancer

  2017cites this paper
• Plasma N-acetylputrescine, cadaverine and 1,3-diaminopropane: potential biomarkers of lung cancer used to evaluate the efficacy of anticancer drugs.

  2017cites this paper
• Prognostic Significance of BMI-1 But Not MEL-18 Expression in Pulmonary Squamous Cell Carcinoma.

  2017cites this paper
• Circulating Bmi-1 mRNA as a diagnostic and prognostic biomarker for non-small cell lung cancer

  2017cites this paper
• Plasma N-acetylputrescine, cadaverine and 1,3-diaminopropane: potential biomarkers of lung cancer used to evaluate the efficacy of anticancer drugs

  2017cites this paper
• Prognostic and clinicopathological significance of ubiquitin-specific protease 22 overexpression in cancers: evidence from a meta-analysis

  2017cites this paper
• Pluripotency transcription factors in lung cancer—a review

  2016cites this paper
• Expression of PTEN and Its Correlation with Proliferation Marker Ki-67 in Head and Neck Cancer

  2016cites this paper
• Prostate cancer stem cells : potential new biomarkers

  2016influential citation
• PTEN expression is associated with the outcome of lung cancer: evidence from a meta-analysis.

  2016cites this paper
• Expression of microRNA-452 via adenoviral vector inhibits non-small cell lung cancer cells proliferation and metastasis

  2016cites this paper
• Ubiquitin-specific peptidase 22 functions and its involvement in disease

  2016cites this paper
• DUBbing Cancer: Deubiquitylating Enzymes Involved in Epigenetics, DNA Damage and the Cell Cycle As Therapeutic Targets

  2016cites this paper
• Expression and survival significance of B-cell-specific Moloney murine leukemia virus integration site 1 and matrix metalloproteinase-9 in non-small-cell lung cancer

  2016influential citation
• Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.

  2016cites this paper
• The relationship between the expression of USP22, BMI1, and EZH2 in hepatocellular carcinoma and their impacts on prognosis

  2016cites this paper
• PTEN expression is a prognostic marker for patients with non-small cell lung cancer: a systematic review and meta-analysis of the literature

  2016cites this paper
• The deubiquitinating enzyme activity of USP22 is necessary for regulating HeLa cell growth.

  2015cites this paper
• Downregulated miR-45 Inhibits the G1-S Phase Transition by Targeting Bmi-1 in Breast Cancer

  2015cites this paper
• USP22 promotes tumor progression and induces epithelial-mesenchymal transition in lung adenocarcinoma.

  2015cites this paper
• Bmi-1 expression modulates non-small cell lung cancer progression

  2015cites this paper
• Epigenetics of lung cancer.

  2015cites this paper
• Expression of B cell-specific Moloney murine leukemia virus integration site 1 in vulvar squamous cell carcinoma and its effect on the biological behavior of A-431 cells

  2015cites this paper
• Usp22 deficiency impairs intestinal epithelial lineage specification in vivo

  2015cites this paper
• MicroRNA-218 inhibits bladder cancer cell proliferation, migration, and invasion by targeting BMI-1

  2015cites this paper
• Negative regulation of Bmi-1 by AMPK and implication in cancer progression

  2015cites this paper
• Prognostic value of the expression of phosphatase and tensin homolog and CD44 in elderly patients with refractory acute myeloid leukemia.

  2015cites this paper
• Ubiquitin specific protease 22 promotes cell proliferation and tumor growth of epithelial ovarian cancer through synergy with transforming growth factor β1.

  2015cites this paper
• Prognostic role of high Bmi-1 expression in Asian and Caucasian patients with solid tumors: a meta-analysis.

  2014cites this paper
• Deregulation of Bmi-1 is associated with enhanced migration, invasion and poor prognosis in salivary adenoid cystic carcinoma.

  2014cites this paper
• USP22 Promotes NSCLC Tumorigenesis via MDMX Up-Regulation and Subsequent p53 Inhibition

  2014cites this paper
• Ubiquitin-specific protease 22: a novel molecular biomarker in glioma prognosis and therapeutics

  2014cites this paper
• Collaborative network of predictive markers complicates formation of prognostic groups in patients with advanced lung cancer.

  2014cites this paper
• USP22 regulates oncogenic signaling pathways to drive lethal cancer progression.

  2014cites this paper
• USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.

  2014cites this paper
• USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma

  2014cites this paper
• RNA interference-mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest

  2013cites this paper
• Usp22 and its evolving role in systemic carcinogenesis.

  2013cites this paper
• IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance

  2013cites this paper